Evidence map›Paper›PMID 32545318›Full record

ArticleMicroorganisms2020

Next-Generation Sequencing of the Whole Bacterial Genome for Tracking Molecular Insight into the Broad-Spectrum Antimicrobial Resistance of

Evariste Tshibangu-Kabamba, Patrick de Jesus Ngoma-Kisoko, Vo Phuoc Tuan, Takashi Matsumoto, Junko Akada, Yasutoshi Kido, Antoine Tshimpi-Wola, Pascal Tshiamala-Kashala, Steve Ahuka-Mundeke, Dieudonné Mumba Ngoy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Low-Abundance and FragmentaryBiomolecules · 2026
    Article
  4. High Levels ofMicroorganisms · 2026
    Article
  5. Article
  6. Antibiotic Resistance and Genetic Determinants ofInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Journal of the National Cancer Center · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Antibiotic Resistance ofJournal of Korean medical science · 2024
    Review
  14. Novel therapeutic regimens againstFrontiers in microbiology · 2024
    Review
  15. A Mini-review onEndocrine, metabolic & immune disorders drug targets · 2024
    Review
  16. Article
  17. Biofilm ofAntibiotics (Basel, Switzerland) · 2023
    Review
  18. Antibiotic Resistance, Susceptibility Testing and Stewardship inInternational journal of molecular sciences · 2023
    Review
  19. Whole Genome Sequencing for StudyingAntibiotics (Basel, Switzerland) · 2023
    Article
  20. Global Antimicrobial Resistance Gene Study ofAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Evariste Tshibangu-KabambaDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Patrick de Jesus Ngoma-KisokoDepartment of Internal Medicine, Gastroenterology and Hepatology Section, Faculty of Medicine, University of Kinshasa, Kinshasa, Congo.
Vo Phuoc TuanDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Takashi MatsumotoDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Junko AkadaDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Yasutoshi KidoDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Antoine Tshimpi-WolaDepartment of Internal Medicine, Gastroenterology and Hepatology Section, Faculty of Medicine, University of Kinshasa, Kinshasa, Congo.
Pascal Tshiamala-KashalaDepartment of Internal Medicine, Gastroenterology and Hepatology Section, Astryd Clinics, Kinshasa, Congo.
Steve Ahuka-MundekeDepartment of Virology, National Institute of Biomedical Research, Kinshasa, Congo.
Dieudonné Mumba NgoyDepartment of Parasitology, National Institute of Biomedical Research, Kinshasa, Congo.
Ghislain Disashi-TumbaDepartment of Internal Medicine, Faculty of Medicine, University of Mbujimayi, Mbujimayi, Congo.
Yoshio YamaokaDepartment of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Oita University · JPUniversity of Kinshasa · CDBaylor College of Medicine · USNational Institute of Biomedical Research · CDUniversity of Mbuji Mayi · CD

Funding

Ministry of Education, Culture, Sports, Science and Technology 26640114, 15H02657, 16H05191, 16H06279, 18KK0266, and 19H03473NIH HHS DK62813
6 · The paper itself

Abstract

Antimicrobial susceptibility testing (AST) is increasingly needed to guide the

Indexed as

Africaantimicrobial susceptibility testingDemocratic Republic of Congodrug resistanceHelicobacter pylorinext-generation sequencingwhole genome sequencing

Identifiers

PMID32545318
PMCPMC7356661
OpenAlexW3035209896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.